TOBACCO ADDICTION
The use of tobacco quickly produces a dependency as much physical as psychological. The fundamental cause of this dependence is nicotine, which has a high addictive capacity.
Tobacco increases the risk of lung cancer in men 25 fold and in woman 12,5 fold. For heavy smokers (more than 25 cigarettes per day) the risk of developing diseases is 40 times higher than in non smokers. Addiction to tobacco increases the risk of cancer of mouth, lip and pharynx eightfold and to a lesser proportion cancer of the estomach, oesophagus and bladder.
Treatments recommended by this Pharmacy are aids to stop smoking provided that the patient is pre-disposed to give up smoking.
CHANTIX (vareniclina)
chantix
www.chantix.com
Chantix (Pfizer) is specifically designed to partially activate the nicotinic receptor and reduce the severity of the smoker's craving and the withdrawal symptoms from nicotine. Moreover, if a person smokes a cigarette while receiving treatment, Chantix has the potential to diminish the sense of satisfaction associated with smoking. This may help to prevent the cycle of nicotine addiction.

NICOBLOC

NicoBloc is the next generation aid to stop smoking. It's a completely natural product which reduces the amount of nicotine and tar you inhale from the cigarettes you smoke. Used over a short period, it will reduce your body's dependence on nicotine, whilst helping to protect you from withdrawal symptoms while you quit smoking.
www.nicobloc.com
ZYNTABAC 50 mg. 60 tablets
(bupropion hydrochloride)
Diminishes the desire to smoke. The treatment is of a 7-12 weeks duration.
NICOTINELL
(nicotine patches)
NICOTINELL
These patches provide the quantity of nicotine necessary to reduce the symptoms of craving whilst giving up smoking. It gradually reduces nicotine levels over a period of three months until such time as the body is able to do without.

 

LEGAL INFORMATION
  • General conditions: the information provided from Roser Miro Pharmacy's Web is directed to complement, not to substitute the existent relationship between a patient and his or her doctor.
  • Privacy and confidentiality policy: Whatever communication conveyed through the Web of Roser Miró Pharmacy is strictly confidential; although the electronic addresses and their content can be kept, your information will not be shared with any external source.
  • Legislation: This Web is managed by Roser Miró pharmacy, legally established in Escaldes, Principality of Andorra. The terms and conditions of usage of this Web are protected under the laws that rule in Andorra. Equally all its products and medicines have been authorized by the Health and Social Health Ministry of the Government of Andorra.
  • Links: The Web of the pharmacy contains links to other Webs, normally those of the labs which manufacture the different products. These links are offered as services and information to provide the maximum information about the products, medicines and treatments, relative to health and well-being.
  • Financing and advertising: This Web neither receives nor has any financing from advertising.
  • The information of this web has been produced by the pharmacists of Roser Miró Pharmacy's team, starting from approvals and subsequent information from the European medicines agency www.emea.europa.eu and the USA Food and Drug administration www.fda.gov and from the manufacturing pharmaceutical laboratories.

Webmaster: fidex@andorra.ad

Last modified: 7th February 2009